Kamada Ltd. (KMDA)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$7.92
-0.81%
Mkt Cap $456.94M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$13.00
Range $11.00 – $15.00
Implied Upside
+64.1%
Consensus $13.00 vs current $7.92